How has proteomics informed transfusion biology so far?

@article{Liumbruno2010HowHP,
  title={How has proteomics informed transfusion biology so far?},
  author={G. Liumbruno and A. D’Alessandro and G. Grazzini and L. Zolla},
  journal={Critical reviews in oncology/hematology},
  year={2010},
  volume={76 3},
  pages={
          153-72
        }
}
Since the genomic era has not fully kept its promises, studies addressing the protein complement to the genome have been recently gaining momentum. Proteomics investigations could be potentially used from bench to bedside, in order to test the quality of collected blood components prior to or during storage. In parallel, proteomics could be used to verify the effects of the production and pathogen reduction processes of plasma derivatives and blood components on the protein fractions, or to… Expand
Proteomics for quality-control processes in transfusion medicine
TLDR
Proteomic strategies have been demonstrated to be also suited to verify the effects of the production and pathogen-reduction processes of plasma derivatives and blood components on the protein fractions, or to discover particular biomarkers readily adoptable for targeted evaluation of blood-component integrity or functionality. Expand
Transfusion medicine and proteomics: an alliance for blood quality and safety.
  • G. Grazzini
  • Medicine
  • Blood transfusion = Trasfusione del sangue
  • 2010
TLDR
The final aim of this joint effort is to investigate to which extent proteomic applications are valuable tools for the study of blood products and what is their potential to improve the understanding of some crucial aspects of collection, processing and storage of red blood cells. Expand
Proteomics applied to transfusion plasma: the beginning of the story
TLDR
The use of proteomics for the Evaluation of the impact of storage conditions and pathogen inactivation treatments applied to transfusion plasma and for the evaluation of therapeutic protein fractionated is discussed. Expand
Proteomics of blood and derived products: what’s next?
TLDR
The current challenge is developing a closer relationship between transfusion medicine and proteomics, by focusing first on the proteome identification of blood products and then on the applications and future developments within the field of proteomics and blood products. Expand
Transfusion science: Integration of proteomics with blood banking
TLDR
This review summarizes the current status of proteomic applications to blood banking and provides a perspective of the future. Expand
Proteomic applications in blood transfusion: working the jigsaw puzzle
TLDR
The technology of proteomics and its application to transfusion medicine is reviewed with specific reference to the analysis of blood products, both fractionated and fresh. Expand
Blood and Plasma Proteomics: Targeted Quantitation and Posttranslational Redox Modifications.
TLDR
The design and production of heavy isotope-labeled peptides used as reporter internal standards for absolute protein quantification and a redox proteomics approach to optimize sample preparation and database searching to elucidate oxidative modifications to protein amino acids are described. Expand
Classic and alternative red blood cell storage strategies: seven years of "-omics" investigations.
TLDR
The present review summarises the main outcomes of the extensive collaboration with the laboratory of proteomics and metabolomics at Tuscia University, Viterbo, Italy, while putting the results in the broader framework of laboratory research in the field of transfusion medicine. Expand
The proteomics and interactomics of human erythrocytes
TLDR
This minireview describes how proteomics and interactomics tools have been used to probe critical protein changes in disorders impacting the blood and describes the work done on sickle cell disease. Expand
Proteomic Analysis of β-Thalassemia/HbE: A Perspective from Hematopoietic Stem Cells (HSCs)
TLDR
Under ineffective erythropoiesis, in-depth analyses of various proteome profiles revealed many of which have putative functions, and dysregulated cell death and survival signaling pathways could explain the deleterious pathogenesis of β-thalassemia/HbE. Expand
...
1
2
...

References

SHOWING 1-10 OF 217 REFERENCES
Transfusion medicine in the era of genomics and proteomics.
Viewing recent trends in transfusion medicine (TM), the authors make predictions about possible future developments within this specialty including greater cost-effectiveness and blood safetyExpand
Transfusion medicine in the era of proteomics.
TLDR
Proteomics can play a potentially relevant role in transfusion medicine (TM) to assess the protein composition of blood-derived therapeutics, particularly for identifying modified proteins. Expand
Blood-related proteomics.
TLDR
Proteomics has been recently transformed from a mere basic-research extremely-expensive toy into a dramatically-sensitive and efficient eye-lens to either delve into the depths of the molecular mechanisms of blood and blood components or to establish quality parameters in the blood-banking production chain totally anew. Expand
How will haematologists use proteomics?
TLDR
The technologies available for the study of the proteome that offer realistic opportunities in haematology are discussed. Expand
Proteomics of Blood-Based Therapeutics
TLDR
As proteomic technologies have the capacity to provide comprehensive information about changes occurring during processing and storage of blood products, proteomics can potentially guide improvement of pathogen inactivation procedures and engineering of stem cells, and may also allow a better understanding of factors influencing the immunogenicity of blood-derived therapeutics. Expand
Proteomics techniques and their application to hematology.
TLDR
This review presents an analysis of the present and future impact of these proteomic technologies with emphasis on relative quantification for hematologic research giving an appraisal of their potential benefits. Expand
Recent advances in blood‐related proteomics
TLDR
Proteomics of red blood cells, until now, has not improved knowledge of these cells, in contrast to the major progresses achieved while studying platelets and leukocytes, and in the future, proteomics will change several aspects of hematology. Expand
Proteomics: applications relevant to transfusion medicine.
TLDR
The present review aims to provide a basic understanding of proteomics research by discussing the methods used to study large numbers of proteins and by reviewing the application of proteomic methods to transfusion medicine. Expand
Proteomics and the haematologist.
TLDR
Rapid large-scale analysis of the proteome in normal pathways and disease offers the opportunity of identification of potential diagnostic/prognostic markers and proteins associated with the malignant phenotype. Expand
Proteomics and transfusion medicine: Future perspectives
TLDR
This review presents what has been done using proteomic tools and the potentials of proteomics for transfusion medicine and the aspects related to peptide and protein changes ignored. Expand
...
1
2
3
4
5
...